Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy.
about
Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brainThe importance of mouse models to define immunovirologic determinants of progressive multifocal leukoencephalopathyMonitoring of pathogen-specific T-cell immune reconstitution after allogeneic hematopoietic stem cell transplantationImmune System Involvement in the Pathogenesis of JC Virus Induced PML: What is Learned from Studies of Patients with Underlying Diseases and Therapies as Risk FactorsT cell epitope mapping of JC polyoma virus-encoded proteome reveals reduced T cell responses in HLA-DRB1*04:01+ donorsFunctional energetics of CD4+-cellular immunity in monoclonal antibody-associated progressive multifocal leukoencephalopathy in autoimmune disordersRole of human leukocyte antigen class I alleles in progressive multifocal leukoencephalopathy.Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.Cross-reactivity of T lymphocytes recognizing a human cytotoxic T-lymphocyte epitope within BK and JC virus VP1 polypeptides.A case of progressive multifocal leukoencephalopathy in a patient treated with infliximab.Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy.Detection of JC virus-specific immune responses in a novel humanized mouse modelAsymptomatic reactivation of JC virus in patients treated with natalizumab.Determinants of survival in progressive multifocal leukoencephalopathyThe polyomavirus BK large T-antigen-derived peptide elicits an HLA-DR promiscuous and polyfunctional CD4+ T-cell response.Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy.Polyomavirus nephropathy in kidney transplantation.Lack of Major Histocompatibility Complex Class I Upregulation and Restrictive Infection by JC Virus Hamper Detection of Neurons by T Lymphocytes in the Central Nervous System.Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis.Definition and characterization of novel HLA-*A02-restricted CD8+ T cell epitopes derived from JCV polyomavirus with clinical relevance.Management of infections by the human polyomavirus JC: past, present and future.Functional signatures of protective antiviral T-cell immunity in human virus infections.Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathyAn SV40 VP1-derived epitope recognized by CD8+ T cells is naturally processed and presented by HLA-A*0201 and cross-reactive with human polyomavirus determinants.Diagnostic assays for polyomavirus JC and progressive multifocal leukoencephalopathyMyelin basic protein-specific T lymphocytes proliferation and programmed cell death in demyelinating diseases.Detection of JC virus-specific cytotoxic T lymphocytes in healthy individuals.Immune surveillance and response to JC virus infection and PML.Natalizumab and progressive multifocal leukoencephalopathy: what are the causal factors and can it be avoided?The human JC polyomavirus (JCPyV): virological background and clinical implications.Immunology of progressive multifocal leukoencephalopathy.Progressive multifocal leukoencephalopathy: Dot-shaped inclusions and virus-host interactions.Role of CD4+ and CD8+ T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome.Archetype JC polyomavirus prevails in a rare case of JC polyomavirus nephropathy and in stable renal transplant recipients with JC polyomavirus viruria.Efficient in vitro expansion of JC virus-specific CD8(+) T-cell responses by JCV peptide-stimulated dendritic cells from patients with progressive multifocal leukoencephalopathy.BKV and JCV large T antigen-specific CD8+ T cell response in HLA A*0201+ kidney transplant recipients with polyomavirus nephropathy and patients with progressive multifocal leukoencephalopathy.JC virus meningitis in a patient with systemic lupus erythematosus.A peptide talk between JC virus and the human host: from silent infection to autoimmunity.
P2860
Q24619923-8E708C5D-6392-43FC-9452-7ECBF70EB381Q26859307-09A926D4-7A37-4E1A-B294-D88FB819F87AQ26861648-D0CCA8E5-879F-4D06-8571-DEC58F708DF8Q28085415-12FE1ABB-7A12-492F-B7F1-D18B362DEF70Q28704590-DCC3704F-6B18-4072-AF87-F42A18136343Q28740884-96349F43-1737-4FB6-9D3C-7F0C6EA9DF72Q33789032-1F2A8F69-90D4-4EF2-B631-67ABECF07D52Q33893285-824AEC11-BFFB-4E45-84D9-A8CA4883C6BBQ33930455-3776F4CD-EF24-4D38-8472-AE531A7864A1Q34132081-CEE56B72-4ADB-47F2-A97A-2D03F8DC115DQ34545686-6EEFDCAF-253F-483D-AC81-51D04736590EQ34735441-30612513-C197-4C08-83DF-39FDD8F8FA5EQ34801034-092DE0D1-0ADE-4290-8082-0779E229E0E8Q35012056-CB848211-0548-4203-9BD6-4EBA6149C3DBQ35066177-B4358C6B-B066-430D-B4DE-96DFD7BC8F78Q35785136-14A9C2D0-84BA-4EB7-B236-C5437425469EQ35841374-460F6FC6-B727-493C-BA25-CED282BF1539Q35864067-82D527BB-C76D-4A56-BC88-3869B0846540Q36143108-C96317C6-6A2C-442A-B03A-0FA17F4F60B9Q36153492-3FFE1D1D-8371-4ECE-B7CA-EF0846768E8DQ36233526-276CFCC2-A09C-4126-B4DA-FFC13E417BFBQ36529008-C7FF3C4E-CAAA-4C44-955D-FDA310D529E3Q36764988-F546D355-E9D5-45DD-B8D9-8CB0CC4C2019Q36766174-C76FD280-928E-4882-BFC7-8F43A8838DB4Q36942417-CDA006AE-A678-4D29-A37F-E9F24C720BCAQ37002062-1FBFF67E-9937-4157-8929-8423646373ADQ37492573-05D113AB-0A16-4609-B1E5-96517E9C76A1Q37678580-D682A0E8-5F3B-4AEE-8BA3-7F6C499F5F8BQ37778944-29B614F5-AAC6-478D-BE3C-ED6D181C32F9Q38115572-56F993EC-9080-427B-B1B8-3B1A2CC546F1Q38367755-A13CC75C-B1EE-47C2-A715-7E1AC34B8D4AQ38462168-1CE09940-8505-41AE-BF4E-BD2D07F4FC9AQ41906877-BD9B69AF-AADB-4C69-9841-8B405521BA88Q41926525-E51DF08A-33D0-400F-9240-827E5E96614DQ43115882-ED443986-3E6A-497F-BC96-751EB721450CQ43132534-B17CCCBD-948D-44AE-B815-19CBDA7DF594Q43426457-7CEE3A49-0639-4888-86E0-3870891B8A21Q45357575-C57CCA1D-D3F9-4B9D-A67A-608957B33B76
P2860
Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Low frequency of cytotoxic T l ...... ultifocal leukoencephalopathy.
@en
type
label
Low frequency of cytotoxic T l ...... ultifocal leukoencephalopathy.
@en
prefLabel
Low frequency of cytotoxic T l ...... ultifocal leukoencephalopathy.
@en
P2093
P2860
P1433
P1476
Low frequency of cytotoxic T l ...... multifocal leukoencephalopathy
@en
P2093
Darci Gorgone
Fred W Peyerl
Igor J Koralnik
Kristi Martin
Marcelo J Kuroda
Michelle Lifton
Norman L Letvin
Patrick Autissier
P2860
P304
11918-11926
P356
10.1128/JVI.77.22.11918-11926.2003
P407
P577
2003-11-01T00:00:00Z